Research Topics
| R A StephensonSummaryAffiliation: University of Utah Country: USA Publications
| Collaborators
|
Detail Information
Publications
Population-based prostate cancer trends in the United States: patterns of change in the era of prostate-specific antigenR A Stephenson
Department of Surgery, University of Utah School of Medicine, Salt Lake City 84132, USA
World J Urol 15:331-5. 1997..Local treatment rates, particularly radical prostatectomy rates, have risen substantially. Mortality rates appear to have leveled or declined slightly since 1991 after years of steady rise...- Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes StudyRobert A Stephenson
From the Division of Urology, University of Utah School of Medicine, Salt Lake City, Utah 8411132, USA
J Urol 174:646-50; discussion 650. 2005..We report use and treatment outcomes in a 5-year interval in a population based cohort from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study... - Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER databaseRobert A Stephenson
Division of Urology, Department of Surgery, University of Utah School of Medicine, 50 North Medical Drive, Room 3B420, Salt Lake City, UT 84132, USA
Urol Clin North Am 29:173-81. 2002..Given the long delay between treatment and mortality that is inherent in prostate cancer (Fig. 14), the full effects of treatment on prostate cancer mortality are probably not yet seen in prostate cancer mortality data... - Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin statusTimothy A Masterson
Division of Urology, Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
Urology 66:152-5. 2005.... - 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes studyDavid F Penson
Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA
J Urol 173:1701-5. 2005..In this study we assessed temporal changes in urinary and sexual function up to 5 years following radical prostatectomy in a population based cohort... - Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes studyArnold L Potosky
Division of Cancer Control and Population Sciences, National Cancer Institute, EPN Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
J Natl Cancer Inst 96:1358-67. 2004..We present treatment-specific quality-of-life outcomes for prostate cancer patients 5 years after initial diagnosis... - Biochemical failure in men following radical retropubic prostatectomy: impact of surgical margin status and locationJoseph A Pettus
Division of Urology, Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA
J Urol 172:129-32. 2004..AM+ conveys a similar risk of recurrence compared with OM+ and MM+. Apical margin status did not independently predict biochemical recurrence... 
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes studyRichard M Hoffman
Medicine Service, New Mexico VA Health Care System, Albuquerque, NM 87108, USA
J Gen Intern Med 18:845-53. 2003..We examined whether there were racial differences in initial treatment for clinically localized prostate cancer and investigated whether demographic, socioeconomic, clinical, or tumor characteristics could explain any racial differences...
Risk stratification for positive lymph nodes in prostate cancerJoseph A Pettus
Department of Urology, University of Utah, Salt Lake City, Utah 84132, USA
J Endourol 22:1021-5. 2008..To evaluate the risk of positive lymph nodes using preoperative clinical parameters...- Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogeneticsJoseph A Pettus
Department of Human Genetics, University of Utah School of Medicine, 1C210 SOM, 30 North 1900 East, Salt Lake City, UT 84132-2117, USA
Cancer Genet Cytogenet 154:110-8. 2004..We propose this technology for the evaluation of prostate and other heterogeneous cancers as a rapid and efficient way to detect genetic copy number changes... - Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes StudyRichard M Hoffman
Medicine Service, New Mexico VA Health Care System, Albuquerque, New Mexico 87108, USA
Cancer 97:1653-62. 2003.... - General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes studyDavid F Penson
Section of Urology, VA Puget Sound Health Care System and the Department of Urology, University of Washington, Seattle, WA 98108, USA
J Clin Oncol 21:1147-54. 2003..The goal of this study was to determine the relationship between primary treatment, urinary dysfunction, sexual dysfunction, and general health-related quality of life (HRQOL) in prostate cancer... - Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapyArnold L Potosky
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD
J Natl Cancer Inst 94:430-7. 2002..Therefore, men considering ADT as an initial treatment should be aware that sexual function and some aspects of physical well-being are likely to be affected in the first year following this treatment...